These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 9223356)
1. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Shryock JC; Belardinelli L Am J Cardiol; 1997 Jun; 79(12A):2-10. PubMed ID: 9223356 [TBL] [Abstract][Full Text] [Related]
2. [The receptorial responsiveness method (RRM): a new possibility to estimate the concentration of pharmacologic agonists at their receptors]. Pák K; Kiss Z; Erdei T; Képes Z; Gesztelyi R Acta Pharm Hung; 2014; 84(1):38-52. PubMed ID: 24809165 [TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Armstrong S; Ganote CE Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060 [TBL] [Abstract][Full Text] [Related]
4. Targeting adenosine receptors in the development of cardiovascular therapeutics. Riksen NP; Rongen GA Expert Rev Clin Pharmacol; 2012 Mar; 5(2):199-218. PubMed ID: 22390562 [TBL] [Abstract][Full Text] [Related]
5. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart. Belardinelli L; Lu J; Dennis D; Martens J; Shryock JC J Pharmacol Exp Ther; 1994 Dec; 271(3):1371-82. PubMed ID: 7996449 [TBL] [Abstract][Full Text] [Related]
6. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists. Jacobson KA; Xie R; Young L; Chang L; Liang BT J Biol Chem; 2000 Sep; 275(39):30272-9. PubMed ID: 10887176 [TBL] [Abstract][Full Text] [Related]
7. Apparent activation of cardiovascular A1 adenosine receptors by A3 agonists. Headrick JP Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H793-6. PubMed ID: 11820196 [No Abstract] [Full Text] [Related]
8. The effect of age on adenosine A1 receptor function in the rat heart. Gao E; Snyder DL; Johnson MD; Friedman E; Roberts J; Horwitz J J Mol Cell Cardiol; 1997 Feb; 29(2):593-602. PubMed ID: 9140818 [TBL] [Abstract][Full Text] [Related]
9. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology of Adenosine Receptors: The State of the Art. Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236 [TBL] [Abstract][Full Text] [Related]
11. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Abbracchio MP; Cattabeni F Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415 [TBL] [Abstract][Full Text] [Related]
14. Xanthine derivatives in the heart: blessed or cursed? Szentmiklósi AJ; Cseppentō A; Gesztelyi R; Zsuga J; Körtvély A; Harmati G; Nánási PP Curr Med Chem; 2011; 18(24):3695-706. PubMed ID: 21774759 [TBL] [Abstract][Full Text] [Related]
15. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Mustafa SJ; Morrison RR; Teng B; Pelleg A Handb Exp Pharmacol; 2009; (193):161-88. PubMed ID: 19639282 [TBL] [Abstract][Full Text] [Related]
19. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. Mullane K; Bullough D J Mol Cell Cardiol; 1995 Apr; 27(4):1041-54. PubMed ID: 7563101 [TBL] [Abstract][Full Text] [Related]
20. The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges. Sousa JB; Diniz C Molecules; 2017 May; 22(5):. PubMed ID: 28481238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]